|
TNF-alfa i
immunopatogenesi 
TNF-alfa en
los pacientes infectados por el
VIH. Valor pronóstico.
Investigador
principal: M. Sala
Beca FIS |
Apoptosis en
pacientes infectados por VIH
Investigador
principal: M. J. Amengual
Beca Fundació Parc Taulí |
| |
|
1994 |
|
TNF production in HIV- infected
patients. Utility as surrogate marker and
relationship with opportunistic
infections. |
|
Sala M, Monteagudo
M, Amengual MJ, Sasal M, Cervantes M,
Segura F |
|
X International
Conference on AIDS. poster PA-0267 ,
Yokohama, 7-12 agost 1994 |
| |
|
1995 |
|
Tumor Necrosis Factor in HIV
infected patients. Correlation with opportunistic diseases. |
|
Sala M, CervantesM,
Sasal M, FontB, SerrateG, Amengual MJ,
Segura F |
|
I International
Symposium Cytokines and HIV, poster,
Reims 1995 |
| |
|
Apoptosis of lymphocytic cells
in HIV infected patients
|
|
Amengual MJ, Sala M,
Sasal M, Cervantes M, Segura F |
|
I International
Symposium Cytokines and HIV, poster,
Reims 1995 |
| |
|
Implicación de TNF-alfa y CD 95
/ Fas en la apoptosis de linfocitos
de pacientes infectados por el VIH. |
|
Amengual MJ, Sala M,
Ustrell R, Monteagudo M,
Cervantes M, Oristrell J, Sasal M, Segura
F |
Jornada de
Investigación sobre la patogenia del
Sida.
Institut Français de Madrid, poster,
octubre de 1995 |
| |
|
1998 |
|
Predicting clinical progression
and death in a cohort of HIV- infected
patients. A comparative analysis of HIV-RNA
and TNF-alfa. |
|
SalaM, CervantesM,
RodriguezM, AmengualMJ, RueM, SasalM,
Segura F |
|
XII International
Conference on AIDS . Poster 42188,
Geneve, 28 jun-3 jul 1998 |
| |
|
1999 |
|
Progression and
mortality in a cohort of HIV-infected
patients in Pre-HAART era: a comparison between viral
load, CD4 and TNF-alpha levels. |
|
Sala M, Cervantes M,
Amengual MJ, SasalM, Font B, Serrate G,
Segura F |
|
39th
ICAAC; September 26-29, 1999; San
Francisco, Calif. Abstract 126. |
|
comentaris
de Graeme Moyle, a
Medscape's ICAAC summaries:
Natural History and
Opportunistic Infections in HIV Disease |
| |
Recursos
assistencials
|
1998 |
|
HAART in clinical practice: the
improvement in parameters of hospital
activity confirms effectiveness of new
therapies. |
|
Cervantes M, Sala M,
Sasal M, Font B, Serrate G, Vidal G,
Segura F |
|
XII International
Conference on AIDS . Poster 42437.Ginebra,
28 jun-3 jul 1998 |
| |
Teràpia antiretroviral
|
1996 |
|
Plasma Viral Load and CD4
changes in naive patients at 3 months
after initiation of combined therapy with
zidovudine and zalcitabine. |
|
Ibañez A, Ruiz L,
Puig T, Gutierrez C, Sanzhez I, Clotet B
and the Group for the Study of Viral Load
in patients undergoing combination
therapy. |
|
XI International
Conference on Aids. poster, Vancouver,
1996 |
| |
|
1997 |
|
Immunological and virological
activity of zalcitabine and zidovudine in
combination in HIV-positive people with
CD4 between 200-500 cells/mm3 |
|
IbáñezA, PeraireJ,
ArnóA, GutiérrezC, CervantesM,
ColomerJ, VillalongaC, CamafortM, RuizL,
BalaguerM, VidalF, Richart C, Clotet B |
|
Antiviral therapy
1997; 2: 105-12 |
| |
|
1998 |
|
Hyperglycemia associated with
protease inhibitor therapy |
|
Sala M, Peña R,
Cervantes M, Font B, Serrate G, Segura F |
|
XII International
Conference on AIDS . Poster 12387 Geneve,
28 jun-3 jul 1998 |
| |
|
1999 |
|
Nelfinavir /
Saquinavir drug levels in two different
dosage schedules: a pilot study
|
|
Dalmau D, Gomez L,
Martinez-Lacasa X,
Cervantes M, Knobel H, Domingo P, Garau J |
|
European Conference
on Clinical Aspects of Aids. Berlin, 1999 |
| |
|
Efficacy of
salvage therapy containing nelfinavir and
saquinavir after failure of single
protease inhibitor containing regimens
|
|
Domingo P, Cervantes
M, Gomez L, Rodriguez Carballeira M,
Pedrol E, Knobel H, Martinez-Lacasa X,
Guardiola J, Sala M, Solé R, Dalmau D |
|
Seventh
European Conference on Clinical Aspects
and Treatment of HIV Infection, poster,
Lisboa, octubre 1999 |
| |
|
Liver function
tests before and after HAART:
longitudinal study of a cohort of 119
patients through six years (1993-99) |
|
Cervantes M, Navarro
M, Sala, Font B, Serrate G, Segura F |
|
Seventh
European Conference on Clinical Aspects
and Treatment of HIV Infection, póster,
Lisboa, octubre 1999 |
| |
|
Prevalence of
AZT and 3TC resistance related mutations
in the absence of active AZT or 3TC use
in a large, multi-centered, comparative
trial
of Genotyping and Standard of Care - The
Havanna Trial |
|
Ruiz L, Tural C,
Holtzer C, Boulme R, Martinez-Picado X,
Vilaro J, Cervantes M,
Ferrer E, Guelar A, Iribarren JA,
Massaveu A, Llibre JM, Peraire J,
Clotet B and the Havanna Study Group. |
4th
International Workshop on Drug Resistance
and Treatment Strategies
Sitges, Barcelona. June 12-16, 2000 |
| |
An open randomized study
comparing d4T + ddI and nevirapine (Qd)
vs d4T + ddI and nevirapine (Bid) in
antiretroviral naive chronic HIV-1
infected patients in very early stages:
Spanish scan study. Final results.
|
F Garcia, H Knobel, MA Sambeat,
J Arrizabalaga, M. Aranda, J Romeu, D
Dalmau,
F Segura, Jose Luis G-S, E Ferrer, Anna
C, T Gallart, T Pumarola, JM Miró, JM
Gatell
|
XIII World Aids Conference,
Durban, july 2000
|
| |
Efficacy of salvage therapy
containing Nelfinavir / Saquinavir
combination and their correlation with
genotypic resistance pattern.
|
D. Dalmau, M. Rodriguez
Carballeira, L. Gomez, E. Pedrol, R.
Sole, H. Knobel,
P. Domingo, M. Cervantes, M. Sala, J.
Guardiola, X. Martinez Lacasa
|
XIII World Aids Conference,
Durban, july 2000
|
| |
|
Comparison of twice-daily
stavudine plus once- or twice-daily
didanosine and nevirapine in early stages
of HIV infection: the Scan Study |
|
Felipe
Garcia, Hernando Knobel, Maria Antonia
Sambeat, Julio Arrizabalaga, Miquel
Aranda, Joan Romeu, David Dalmau, Ferran
Segura, Juan Luis Gomez-Sirvent, Elena
Ferrer, Anna Cruceta, Teresa Gallart,
Tomas Pumarola, Jose M Miro, Jose M
Gatell and The Spanish Scan Study Group |
|
AIDS,
2000;14:2485-94 |
| |
|
Comparison of Immunologic
Restoration and Virologic Response in
Plasma, Tonsillar Tissue, and
Cerebrospinal Fluid in HIV-1–Infected
Patients Treated With Double Versus
Triple Antiretroviral Therapy in Very
Early Stages: The Spanish Earth-2 Study |
|
Felipe
García; María M. Alonso; Joan Romeu;
Hernando Knobel; Julio Arrizabalaga;
Elena Ferrer; David Dalmau; Isabel Ruiz;
Francesc Vidal; Adela Frances; Ferran
Segura; Juan L. Gomez -Sirvent; Anna
Cruceta; Bonaventura Clotet; Tomás
Pumarola; Teresa Gallart; William A.
O'Brien; José M. Miró; José M. Gatell;
Spanish Earth-2 Study |
|
JAIDS,
2000;25:26-35 |
Manifestacions clíniques
|
1992 |
|
Rhodococcus equipulmonary
infection in an HIV infected patient |
|
Sasal M, Roig J,
Cervantes M, Ormaza J, Matas L, Segura F |
|
VIII International
Conference on Aids, Amsterdam, poster, 19.24
juliol 1992 |
| |
|
Good response to antibiotic
treatment of lung infection due to
Rhodococcus equi in a patient infected
with HIV |
|
Sasal M, Roig J,
Cervantes M, Matas L, Segura F |
|
Clin Infect Dis 1992;
15: 747-8 |
| |
|
1993 |
|
Gastric mucormycosis in a
patient with AIDS |
|
Brullet E, Andreu X,
Elias J, Roig J, Cervantes M |
|
Gastrointestinal
Endoscopy 1993; 39:106-7 |
| |
|
Esophageal infection by
cryptococcus and CMV with mediastinal
fistula |
|
Sasal M, Serrate G,
Chapinal O, Brullet E, Cervantes M,
Segura F |
|
IX International
Conference on Aids. Poster B19-1852,
Berlin 6-11 juny 1993 |
| |
|
1994 |
|
Gastric tuberculosis as first
manifestation of AIDS.
Presentation of a case with antral
fistula. |
|
Sasal M, Sala M,
Serrate, Font B, Cervantes M, Segura F |
|
X International
Conference on AIDS. Poster PB-0676,
Yokohama, 7-12 agost 1994 |
| |
|
1995 |
|
Evaluation of a PCR commercial
kit for rapid diagnosis of
tuberculosis in HIV infected patients. |
|
MariscalD, SasalM,
RenauJ, CervantesM, FontanalsD, Segur F,
Torra M |
|
3d Scientific
Meeting European Society of Chemotherapy
Infectious Diseases, Institut Pasteur,
Paris, 18-20 maig 1995 |
| |
|
1996 |
|
Quistes linfoepiteliales de parótida
en pacientes con infección por VIH.
Presentación de 4 casos. |
|
Font J, Sala M,
Sasal M, Donoso L, Segura F, Cervantes M |
|
XX Symposium
Internacional de la Sociedad Española de
Cirujanos de Cabeza y Cuello. Sabadell,
12-14 de desembre 1996 poster |
| |
|
1998 |
|
Aids in the elderly: a challenge
to the internist |
|
Cervantes M,
Nogueras C, Sala M, Segura F, de Nadal J |
|
Congreso Mundial de
la International Society of Internal
Medicine Lima, noviembre de 1998 poster |
| |
|
Hyperglycemia associated with
protease inhibitor therapy |
|
Sala M, Peña R,
Cervantes M, Font B, Serrate G, Segura F |
|
XII International
Conference on AIDS . Poster 12387 Geneve,
28 jun-3 jul 1998 |
| |
|
1999 |
Liver function
tests before and after HAART:
longitudinal study of a cohort of 119
patients through six years (1993-99)
|
|
Cervantes M, Navarro
M, Sala, Font B, Serrate G, Segura F |
|
Seventh
European Conference on Clinical Aspects
and Treatment of HIV Infection, poster,
Lisboa, octubre 1999 |
| |
2000
|
Osteonecrosis in HIV+ patients:
Five more cases of another metabolic
disorder associated with HAART?
|
MCervantes , CNogueras, MSala,
BFont, GSerrate, FSegura, MLarrosa
|
XIII World Aids Conference,
Durban, july 2000
|
| |
|
Neoplasia of
plasma cells with atypical presentation
and infection by the Human Immunodeficiency Virus. A presentation of
two cases |
| Susana
Herranz, Montserrat Sala, Manuel
Cervantes, Mercè Sasal, Alfons Soler,
Ferran Segura |
| American
Journal of Hematology, 2000;65:239-42 |
|